750 EFFICACY AND SAFETY OF ENTECAVIR VERSUS LAMIVUDINE IN TREATMENT-NAÏVE CHRONIC HEPATITIS B PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE: 48 WEEKS RESULTS

2013 ◽  
Vol 58 ◽  
pp. S304
Author(s):  
Y. Zhang ◽  
X.-Y. Hu ◽  
Y.-Y. Wang ◽  
G. Chen ◽  
J. Chen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Liver Failure ◽  
Chronic Hepatitis B ◽  
Chronic Liver ◽  
Efficacy And Safety ◽  
Chronic Liver Failure ◽  
Treatment Naïve

Acute-on-chronic liver failure in chronic hepatitis B: an update

2018 ◽  
Vol 12 (4) ◽  
pp. 341-350 ◽  
Author(s):  
Rui-Hong Zhao ◽  
Yu Shi ◽  
Hong Zhao ◽  
Wei Wu ◽  
Ji-Fang Sheng
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Liver Failure ◽  
Chronic Hepatitis B ◽  
Chronic Liver ◽  
Chronic Liver Failure

scholarly journals The Pathogenesis of Acute on Chronic Hepatitis B Liver Failure

2014 ◽  
Vol 3 (1) ◽  
pp. 31-34
Author(s):  
Zhao-chun Chi ◽  
Quan-jiang Dong ◽  
Chang-xin Geng
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Liver Failure ◽  
Chronic Hepatitis B ◽  
Theoretical Basis ◽  
Accurate Diagnosis ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
Decompensated Liver Cirrhosis ◽  
Immune Injury

Abstract Acute-on-chronic liver failure is a characteristic clinical liver syndrome, which should be differentiated from acute liver failure, acute decompensated liver cirrhosis and chronic liver failure. The pathogenesis of ACLF is not fully understood yet. Viral factors and immune injury have been reported to be the two major pathogenesis. This paper reviewed the researches on the pathogenesis of acute on chronic hepatitis B liver failure in recent years, to provide theoretical basis for prompt and accurate diagnosis and treatment of this syndrome. This would benefit for the prognosis and raise the survival rate of patients.

Sign in / Sign up

Export Citation Format

Share Document